Jump to Main Content
The occurrence, transmission, virulence and antibiotic resistance of Listeria monocytogenes in fish processing plant
- Skowron, Krzysztof, Kwiecińska-Piróg, Joanna, Grudlewska, Katarzyna, Świeca, Agnieszka, Paluszak, Zbigniew, Bauza-Kaszewska, Justyna, Wałecka-Zacharska, Ewa, Gospodarek-Komkowska, Eugenia
- International journal of food microbiology 2018 v.282 pp. 71-83
- Listeria monocytogenes, ampicillin, antibiotic resistance, erythromycin, farms, fish, genes, genetic similarity, meropenem, polymerase chain reaction, pulsed-field gel electrophoresis, serotypes, sulfamethoxazole, trimethoprim, virulence
- The aim of this research was to investigate the occurrence of Listeria monocytogenes in fish and fish processing plant and to determine their transmission, virulence and antibiotic resistance.L. monocytogenes was isolated according to the ISO 11290–1. The identification of L. monocytogenes was confirmed by multiplex PCR method. Genetic similarity of L. monocytogenes strains was determined with the Pulsed-Filed Gene Electrophoresis (PFGE) method. The multiplex PCR was used for identification of L. monocytogenes serogroups and detection of selected virulence genes (actA, fbpA, hlyA, iap, inlA, inlB, mpl, plcA, plcB, prfA). The L. monocytogens isolates susceptibility to penicillin, ampicillin, meropenem, erythromycin, trimethoprim/sulfamethoxazole was evaluated with disc diffusion method according to EUCAST v. 7.1.The presence of 237 L. monocytogenes isolates (before genetic similarity assessment) in 614 examined samples was confirmed. After strain differentiation by PFGE techniques the presence of 161 genetically different strains were confirmed. The genetic similarity of the examined isolates suggested that the source of the L. monocytogenes strains were fishes originating from farms. All tested strains possessed all detected virulence genes. Among examined strains, the most (26, 38.6%) belonged to the group 1/2a-3a. The most of tested strains were resistant to erythromycin (47.1%) and trimethoprim/sulfamethoxazole (47.1%).